Bio-Path Becomes Public in Merger with Ogden Golf March 5, 2008 By Catherine Hollingsworth No Comments
Bio-Path Becomes Public in Merger with Ogden Golf March 5, 2008 By Catherine Hollingsworth No Comments
Regeneron IL-1 Blocker Arcalyst Not Seen as Rival to Kineret Feb. 29, 2008 By Catherine Hollingsworth No Comments
Regeneron IL-1 Blocker Arcalyst Not Seen as Rival to Kineret Feb. 29, 2008 By Catherine Hollingsworth No Comments
Receptor Logic Finds Partner to Develop T-Cell Mimics Feb. 28, 2008 By Catherine Hollingsworth No Comments
